From October 1, 2023 to December 31, 2023, the company has repurchased 95,700 shares, representing 0.27% for ¥315.81 million. With this, the company has completed the repurchase of 1,005,900 shares, representing 2.76% for ¥3,242.99 million under the buyback announced on May 15, 2023.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2,995 JPY | -0.33% | -1.96% | -8.41% |
Apr. 25 | Hidehiro Imatsu named president of Goldman Sachs Japan | RE |
Mar. 21 | Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023. | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-8.41% | 683M | |
+36.64% | 723B | |
+31.08% | 598B | |
-3.25% | 364B | |
+20.15% | 331B | |
+3.95% | 288B | |
+16.04% | 244B | |
+9.85% | 210B | |
-5.03% | 208B | |
+9.01% | 169B |
- Stock Market
- Equities
- 4534 Stock
- News Mochida Pharmaceutical Co., Ltd.
- Tranche Update on Mochida Pharmaceutical Co., Ltd.'s Equity Buyback Plan announced on May 15, 2023.